Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatment

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: onr:"swepub:oai:DiVA.org:oru-93745" > Age, margin status,...

1 av 1
Föregående post
Nästa post
Till träfflistan

Andersson, SoniaDepartment of Women's and Children's Health, Obstetrics‑Gynecology Division, Karolinska Institute, Stockholm, Sweden (författare)

Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatment

Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

2021-07-27
Spandidos Publications,2021
printrdacarrier

Nummerbeteckningar

LIBRIS-ID:oai:DiVA.org:oru-93745
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-93745URI
https://doi.org/10.3892/ol.2021.12945DOI
http://kipublications.ki.se/Default.aspx?queryparsed=id:147246956URI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

The present study aimed to identify the factors that independently contribute to disease recurrence among women first-time treated for high-grade cervical intraepithelial neoplasia (CIN) during 4-6 years of follow-up. Overall, 529 of 530 eligible patients participated; these patients all attended a 1st follow-up appointment similar to 6 months post-conization, at which time high-risk human-papillomavirus (HPV) testing, liquid-based cytology and colposcopy were performed. Full data on margin excision status, other aspects of initial treatment and comorbidity were obtained. At least one subsequent follow-up was attended by 88% of patients. A total of 22 recurrent cases were detected during follow-up. Detected recurrence was the outcome of focus for multiple logistic regression analysis, with odds ratios (OR) and 95% confidence intervals (CI) computed. Four significant independent risk factors were identified: Age 45 years or above (OR=3.5, 95% CI=1.3-9.9), one or both unclear or uncertain margins (OR=5.3, 95% CI=2.0-14.2), positive HPV at 1st follow-up (OR=5.8, 95% CI=2.0-16.8), and abnormal cytology at 1st follow-up (OR=3.9, 95% CI=1.4-11.0). Bivariate analysis revealed that persistent HPV positivity was associated with recurrence (P<0.01). These findings indicated that incomplete excision of the CIN lesion may warrant more intensive subsequent screening, regardless of early post-conization HPV findings. Although early post-conization positive HPV was a powerful, independent predictor of recurrent high-grade CIN, over one-third of the patients with detected recurrence had a negative early post-conization HPV finding. These patients returned for routine screening, at which time, in most cases, HPV status was positive, thus indicating the need for repeated HPV evaluation. Especially during the on-going pandemic, home vaginal self-sampling is recommended. Particular attention is required for women aged >= 45 years. In addition, although not statistically significant, relevant comorbidities, especially autoimmune conditions, warrant consideration in clinical decision-making. Women who have been treated for high-grade CIN are at risk for recurrent disease and progression to cervical cancer; therefore, they require careful, individualized follow-up to avoid these adverse consequences.

Ämnesord och genrebeteckningar

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
cervical intraepithelial neoplasia
treatment failure
margin status
papillomavirus infection
age

Biuppslag (personer, institutioner, konferenser, titlar ...)

Megyessi, DavidDepartment of Women's and Children's Health, Obstetrics‑Gynecology Division, Karolinska Institute, Stockholm, Sweden (författare)
Belkic, KarenKarolinska Institutet (författare)
Alder, SusannaKarolinska Institutet (författare)
Östensson, EllinorDepartment of Women's and Children's Health, Obstetrics‑Gynecology Division, Karolinska Institute, Stockholm, Sweden (författare)
Mints, Miriam,1958-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Women's and Children's Health, Obstetrics‑Gynecology Division, Karolinska Institute, Stockholm, Sweden(Swepub:oru)mms (författare)
Karolinska InstitutetDepartment of Women's and Children's Health, Obstetrics‑Gynecology Division, Karolinska Institute, Stockholm, Sweden (creator_code:org_t)

Sammanhörande titlar

Ingår i:Oncology Letters: Spandidos Publications22:31792-10741792-1082

Internetlänk

Hitta via bibliotek

Oncology Letters (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

1 av 1
Föregående post
Nästa post
Till träfflistan

Hitta mer i SwePub

Av författaren/redakt...: Andersson, Sonia; Megyessi, David; Belkic, Karen; Alder, Susanna; Östensson, Ellin ...; Mints, Miriam, 1 ...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Cancer och onkol ...

Artiklar i publikationen: Oncology Letters

Av lärosätet: Örebro universitet; Karolinska Institutet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se